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Mirizzi’s syndrome masquerading as
cholangiocarcinoma: a case report
Muhammad Rizwan Khan2* and Sameer ur Rehman1
Abstract
Introduction: Mirizzi’s syndrome is a rarely observed disorder that presents with obstructive jaundice. The
condition is caused by a stone impacted in the gall bladder neck or cystic duct that impinges on the common
hepatic duct, with or without a cholecystocholedochal fistula. The condition is often confused with other serious
conditions such as hilar cholangiocarcinoma, which present with similar clinical and imaging findings, and a pre-
operative diagnosis may be a serious challenge.
Case presentation: We present the case of a 44-year-old Asian man with Mirizzi’s syndrome who was initially
diagnosed as having cholangiocarcinoma based on his clinical presentation, raised cancer antigen 19–9 levels and
radiological findings. Our patient was diagnosed as having Mirizzi’s syndrome intra-operatively and subsequently a
cholecystectomy was performed with restoration of biliary drainage. Careful clinical assessment during surgery with
the help of intra-operative frozen section helped in establishing the definitive diagnosis and altered the surgical
procedure for our patient.
Conclusions: Pre-operative diagnosis of Mirizzi’s syndrome could be challenging as the clinical, biochemical and
radiological presentation is similar to other conditions causing obstructive jaundice such as choledocholithiasis, bile
duct stricture or cholangiocarcinoma. A high index of suspicion and careful surgical assessment may help in
establishing a diagnosis and alter the clinical course for our patient.
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Introduction
Mirizzi’s syndrome (MS) is a rarely observed condition
characterized by impaction of stones in the neck of the
gall bladder or cystic duct, causing mechanical obstruc-
tion of the common hepatic duct and presents clinically
as intermittent or persistent jaundice. This syndrome
was first described in 1948 by an Argentinean surgeon,
Pablo Mirizzi [1]. The accurate diagnosis of Mirizzi’s
syndrome is of particular importance to surgeons as the
condition may be confused with choledocholithiasis, bile
duct stricture or cholangiocarcinoma on initial presenta-
tion and hence the surgical treatment is associated with
a significantly increased risk of inadvertent bile duct in-
jury [2,3]. We report the case of a 44-year-old man with
Mirizzi’s syndrome who was initially diagnosed as having
cholangiocarcinoma based on his clinical presentation,
raised cancer antigen (CA)19-9 levels and radiological
findings.
Case presentation
A 44-year-old Asian man, an agriculturalist by occupa-
tion, presented to a local hospital with a four-day history
of upper abdominal pain and vomiting. He also had his-
tory of progressively increasing jaundice for the last two
months. He had significant comorbid conditions includ-
ing hypertension and ischemic heart disease for which
he underwent a coronary artery bypass grafting two
years previously. A clinical diagnosis of cholangitis was
made at presentation. He was resuscitated and an ab-
dominal ultrasound (US) followed by endoscopic retro-
grade cholangiopacreaticography (ERCP) was performed.
ERCP revealed a tight stricture involving the proximal
bile duct extending to the confluence of right and left
hepatic ducts (Figure 1). A plastic stent was placed to
drain the biliary system. Unfortunately, the clinical
course was complicated by ERCP-induced pancreatitis
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and our patient was transferred to our hospital for fur-
ther management. On examination, he was deeply icteric
and dehydrated, with marked tenderness in the upper
abdomen. His blood investigations showed leukocytosis
and markedly deranged liver functions with a total bili-
rubin level of 25.7mg/dL (normal range 0.1 to 1.2mg/
dL), serum glutamic pyruvic transaminase of 27IU/L
(normal range 0 to 45IU/L), serum glutamic oxaloacetic
transaminase of 53IU/L (normal range 0 to 35IU/L), and
alkaline phosphatase of 248IU/L (normal range 45 to
129IU/L). His serum amylase level was 118IU/L (normal
range 28 to 100IU/L) and lactate dehydrogenase level
was 790IU/L (normal range 266 to 500IU/L). Repeat US
of the abdomen showed a distended gall bladder with
multiple calculi within its lumen, moderate intra-hepatic
biliary dilatation and no pneumobilia. He was resusci-
tated for two days, but his abdominal pain persisted and
bilirubin level continued to rise. Subsequently, his biliary
system was drained by a percutaneously placed external
biliary drain and the previously placed stent was
removed. The clinical condition of our patient gradually
improved and he was started on an oral diet.
In order to delineate the underlying pathology, further
investigation was performed. His CA19-9 levels were
found to be elevated at 71.10U/mL (normal range 0 to
33U/mL, median 5.0U/mL). A computed tomography
(CT) scan of his abdomen showed moderately dilated
intra-hepatic ducts up to the porta hepatis, soft tissue
thickening involving the gall bladder neck and proximal
bile duct and a few enlarged upper abdominal nodes.
The findings were suggestive of neoplastic lesion involv-
ing the gall bladder neck and proximal common bile
duct causing bile duct stricture (Figures 2 and 3). Taking
into consideration the findings from the ERCP, CA19-9
level, and CT scan findings, a provisional diagnosis of
cholangiocarcinoma involving the gall bladder neck was
made.
Six weeks after his initial presentation, our patient was
scheduled for resection of the tumor. On surgical ex-
ploration, a thick-walled gall bladder was seen with a
large stone impacted in the cystic duct causing external
compression on the common hepatic duct (Mirizzi’s syn-
drome). After mobilization of the gall bladder, an intra-
operative cholangiogram showed some decrease in dis-
tensibility of the bile duct, but no filling defect, tumor or
stricture was identified (Figure 4). In view of the high
clinical suspicion, a biopsy of the lateral wall of the bile
duct wall was performed and sent for frozen section,
which was reported as benign. Eventually a cholecystec-
tomy was performed and a T-tube was placed in the bile
duct for temporary external drainage of bile. Tissue from
the gall bladder sent for histopathology also tested nega-
tive for malignancy. The post-operative course of our
patient was uneventful, and our patient was discharged
Figure 1 Initial cholangiogram during endoscopic retrograde
cholangiopacreaticography showing a tight stricture of
proximal common bile duct; a stent was placed in for biliary
drainage.
Figure 2 Axial view of the computed tomography scan of our
patient showing soft tissue thickening at the gall bladder neck
and proximal bile duct region.
Figure 3 Sagittal view of the computed tomography (CT) scan
of our patient showing soft tissue thickening at the gall
bladder neck and proximal bile duct region.
Khan and ur Rehman Journal of Medical Case Reports 2012, 6:157 Page 2 of 4
http://www.jmedicalcasereports.com/content/6/1/157
on the fifth post-operative day with normal bilirubin and
hepatic enzyme levels. Our patient remains well at 18-
month follow-up.
Discussion
Mirizzi’s syndrome is a rare condition characterized by
presence of a common hepatic duct obstruction caused
by an extrinsic compression of an impacted stone in
Hartmann’s pouch or the cystic duct. It presents in ap-
proximately 0.35% of cholecystectomies performed [4].
Predisposing factors include a long intra-mural cystic
duct or a low insertion of the cystic duct into the com-
mon bile duct. Mirizzi’s syndrome was divided into two
types by McSherry. In type I there is external compres-
sion on the hepatic duct without a fistula, whereas in
type II a cholecystocholedochal fistula has been created
by external stone compression [5]. In 1989, Csendes
classified this syndrome as follows: type I, external com-
pression and obstruction of hepatic duct; type II, chole-
cystobiliary fistula with erosion of less than one-third of
the circumference of the hepatic duct; type III, cholecys-
tobiliary fistula with erosion of two-thirds of the circum-
ference; and type IV, total destruction of the hepatic
duct [6]. This classification was further modified by
Csendes in 2007, and type V was added; this consists of
any type of the above classification plus a cholecystoen-
teric fistula without (type Va) or with (type Vb) gallstone
ileus [7].
Patients usually present with clinical and biochemical
signs of biliary obstruction, sometimes in the setting of
an acute cholecystitis, acute cholangitis or pancreatitis.
There is usually a chronic history of biliary symptoms
and CA19-9 levels may be moderately elevated, as seen
in our patient. However there have been a few case
reports where very high levels of CA19-9 along with
other suggestive radiological findings have been thought
of as cholangiocarcinoma [3,8,9]. In our patient, the
ERCP and CT scan findings were highly suggestive of
neoplastic lesion involving the gall bladder and the prox-
imal common bile duct causing luminal narrowing.
Whether CA19-9 should be used in the clinical diag-
nostic investigation of patients with biliary tract diseases
still remains a difficult question to answer. CA19-9 is
synthesized from normal human pancreatic and biliary
ductal cells. Because the exact pathway between tissue
and blood is unknown, the actual mechanism for ele-
vated serum CA19-9 concentration is uncertain. It
seems that extremely high and continuously increasing
CA19-9 levels, together with well assessed clinical infor-
mation, may point towards neoplasia [10]. However, this
is not always the case as seen in our patient and also
reported by others [3]. In view of such reports, the
serum level of CA19-9 should probably never be
regarded as a gold standard but rather as a helpful ad-
junct when searching for biliary malignancy. The diag-
nosis should always take into account medical history,
clinical examination, qualitative radiology studies, and
careful follow-up. If all of the above features are suggest-
ive, a high serum CA19-9 value may be of great help in
favor of a diagnosis of biliary malignancy.
Pre-operative diagnosis of Mirizzi’s syndrome is crucial
in order to avoid complications of unrecognized chole-
cystobiliary or cholecystoenteric fistulas and damage to
the common hepatic duct during surgery. For this rea-
son, the pre-operative diagnosis requires the use of com-
bined imaging modalities such as US, CT, ERCP, and
percutaneous transhepatic cholangiography (PTC). US
or CT scans are not often definitive, although both may
demonstrate findings that strongly suggest a diagnosis,
such as: (1) dilatation of the biliary tree above the level
of the gall bladder neck, (2) impaction of a stone in the
gall bladder neck, and (3) abnormal caliber common bile
duct below the level of impaction. All these findings may
also be present in obstruction caused by a neoplastic le-
sion; hence specificity remains an issue. The radiological
appearance of this condition may be misinterpreted as a
tumor of the gall bladder or cystic duct, a cholangiocar-
cinoma, metastatic disease of the hilum or acute chole-
cystitis [11]. A similar radiological picture raised the
suspicion of cholangiocarcinoma in our patient.
ERCP is considered an effective pre-operative method
for diagnosing the condition in these patients and can pro-
vide a relatively accurate localization and characterization
of the cause of the biliary obstruction. Typical findings of
Mirizzi’s syndrome at ERCP include (1) mid-bile duct ob-
struction with dilated proximal common hepatic duct and
intra-hepatic ducts combined with normal duct caliber
distal to the obstruction, (2) insertion of the cystic duct at
the point of obstruction and/or complete obliteration of
Figure 4 Intra-operative cholangiogram showing some
narrowing of the bile duct due to external compression; note
there is free flow of contrast into the duodenum.
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the cystic duct, and (3) a stone visualized at the point of
obstruction either within the cystic duct or the common
duct [4]. If a stone is not seen or suspected, however, the
findings may be misleading towards a stricture or malig-
nancy. In addition, an interesting finding that suggests
Mirizzi’s syndrome indirectly during ERCP is the fact that
biliary tree dilatation may subside when a patient is placed
in an anti-Trendelenburg position [12].
Although diagnostic imaging techniques have been
perfected, pre-operative diagnosis of Mirizzi’s syndrome
is not an easy task and continues to be a challenge for
the surgeon. Therefore, even intra-operative cautious
recognition of the condition and application of the ap-
propriate surgical judgment according to the characteris-
tics of each case will lead to successful treatment.
Surgical intervention remains the definitive treatment
for the majority of patients and should satisfy three
goals: extraction of the obstructing stone, removal of the
gall bladder, and restoration of normal biliary drainage.
An intra-operative cholangiogram should be obtained
for clarification and confirmation [13,14]. Depending on
the pre-operative diagnosis and operative findings, fro-
zen section pathologic analysis may be indicated to as-
sess the specimen for malignancy, as the associated
incidence of carcinoma with Mirizzi’s syndrome has
been noted to be as high as 27.8%, presumably second-
ary to chronic inflammation [15]. In our patient, the
diagnosis of Mirizzi’s syndrome was made on surgical
exploration and eventually a cholecystectomy with res-
toration of normal biliary drainage was carried out. Tis-
sue samples sent for histopathology tested negative for
malignancy.
Conclusions
Despite improvements in clinical, biochemical and
radiological investigation techniques, pre-operative diag-
nosis of Mirizzi’s syndrome remains a challenging task.
The condition can easily be confused with choledocholi-
lithisis, bile duct stricture or cholangiocarcinoma be-
cause of the close resemblance of radiological findings
and may be overlooked due to the rarity of the condi-
tion. A high index of suspicion and careful surgical as-
sessment may help in establishing a diagnosis and alter
the clinical course for the patient. In our patient, the
diagnosis of Mirizzi’s syndrome was made intra-
operatively and a cholecystectomy was performed with
extraction of the stone and temporary drainage of the
biliary system. Our patient recovered completely with no
complications within a few days.
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